These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2737309)

  • 1. Intratumoural injection of calcium channel blocker enhances cytotoxicity of adriamycin in Ehrlich ascites solid tumour.
    Matsuoka H; Sugimachi K; Kuwano H; Yano K
    Eur J Surg Oncol; 1989 Jun; 15(3):224-31. PubMed ID: 2737309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats.
    Okano H; Ohkubo C
    Bioelectromagnetics; 2005 Dec; 26(8):611-23. PubMed ID: 16189831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effect of a water-in-oil-in-water type adriamycin emulsion on Ehrlich solid tumor-bearing mice].
    Mimaki Y; Shinozawa S; Yasuda K; Yao K; Etwo K; Fukuda T; Araki Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):467-72. PubMed ID: 7184409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.
    Cervato G; Viani P; Galatulas I; Bossa R; Cestaro B
    Anticancer Res; 1986; 6(6):1287-90. PubMed ID: 3813484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo.
    Kusumoto H; Maehara Y; Anai H; Kusumoto T; Sugimachi K
    Cancer Res; 1988 Mar; 48(5):1208-12. PubMed ID: 3342401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonist enhances the effect of adriamycin].
    Matsuoka H; Ueo H; Sugimachi K; Kai H; Matsuura H
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):508. PubMed ID: 4000105
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse.
    Shinozawa S; Araki Y; Oda T
    Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-tumor effect of peritoneal exudate cells (macrophages) exposed to adriamycin].
    Morioka S
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):278-86. PubMed ID: 3713681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
    Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice with Ehrlich ascites cancer].
    Bogush TA; Syrkin AB
    Eksp Onkol; 1985; 7(3):69-71. PubMed ID: 4017936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.